Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Study of CaspaCIDe T Cells (BPX-501; Rivogenlecleucel) From an HLA Partially Matched Family Donor After Negative Selection of TCRαβ+ T Cells in Paediatric Patients Affected by Haematological Disorders

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02065869
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:33.037398+00:00
Published At
2023-01-04T00:00:00+00:00
Record Updated At
2023-09-29
Results Posted At
2023-01-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Lymphoblastic Leukemia", "Leukemia, Acute Myeloid (AML), Child", "Lymphoma, Non-Hodgkin", "Myelodysplastic Syndrome", "Primary Immunodeficiency", "Anemia, Aplastic", "Osteopetrosis", "Hemoglobinopathies", "Cytopenia", "Fanconi Anemia", "Diamond Blackfan Anemia", "Thalassemia", "Anemia, Sickle Cell"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-09-29"
protocolSection.identificationModule.nctId
"NCT02065869"
protocolSection.identificationModule.officialTitle
"Phase I/II Study of CaspaCIDe T Cells (BPX-501; Rivogenlecleucel) From an HLA Partially Matched Family Donor After Negative Selection of TCR\u03b1\u03b2+ T Cells in Paediatric Patients Affected by Haematological Disorders"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-01-04"

Study condition terms

  • Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Leukemia, Acute Myeloid (AML), Child (protocolSection.conditionsModule.conditions)
  • Lymphoma, Non-Hodgkin (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Primary Immunodeficiency (protocolSection.conditionsModule.conditions)
  • Anemia, Aplastic (protocolSection.conditionsModule.conditions)
  • Osteopetrosis (protocolSection.conditionsModule.conditions)
  • Hemoglobinopathies (protocolSection.conditionsModule.conditions)
  • Cytopenia (protocolSection.conditionsModule.conditions)
  • Fanconi Anemia (protocolSection.conditionsModule.conditions)
  • Diamond Blackfan Anemia (protocolSection.conditionsModule.conditions)
  • Thalassemia (protocolSection.conditionsModule.conditions)
  • Anemia, Sickle Cell (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.